Navigation Links
Contributors to Heart Failure Identified
Date:12/14/2009

Twelve variants seen in one gene, researchers say

MONDAY, Dec. 14 (HealthDay News) -- U.S. researchers have pinpointed a dozen genetic variants in a single gene linked to heart failure.

The team at Washington University School of Medicine in St. Louis analyzed the DNA of a large group of white patients with heart failure, and identified 129 variants in four genes that could be connected with heart failure. Further analysis of 1,117 whites with heart failure and 625 healthy whites led the researchers to identify 12 variants on the HSPB7 gene that are associated with heart failure.

Confirmation of this association was achieved by analysis of an independent group of patients, the study authors noted.

For this study, published Dec. 14 in the Journal of Clinical Investigation, the researchers used a technique they recently developed that allows targeted DNA sequencing. They plan to use this same approach to pinpoint additional genetic variants associated with heart failure, a disease influenced by multiple genetic factors.

More information

The American Heart Association has more about heart failure.



-- Robert Preidt



SOURCE: Journal of Clinical Investigation, news release, Dec. 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system
2. Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program
3. New research identifies modifiable risk factors for heart disease
4. Magnetic field measurements of the human heart at room temperature
5. Blood Thinner Combos Risky for Heart Attack Patients
6. Surgery on beating heart thanks to robotic helping hand
7. Renowned Cardiologist Offers Heart Healthy Tips for the Holiday Season
8. Concord Grape Juice Shown to Help Keep Hearts and Minds Healthy
9. Memories That Make Your Heart Race Can Be Defanged
10. Kids Who Beat Cancer Still Face Heart Risks
11. Beating Heart Differs by Gender, Age: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: